Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

The COVID lockdowns at the Shanghai plant began on March 31, and although the plant there has since resumed operations, they are not yet at 100% capacity.

All-cause mortality after one year was 4.6% for the TAVR group and 6.6% for the SAVR group

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the trend toward creating pulmonary embolism (PE) response teams that include cardiology. 

Two late-breaking clinical trials at EuroPCR 2022 in Paris focused on the potential benefits of renal denervation.

According to Medtronic, the Onyx Frontier DES features improved catheter flexibility and a lower crossing profile.

MAVD patients did face a higher risk of requiring a permanent pacemaker, researchers noted, though the reason for this trend remains unclear. 

With physician burnout on the rise and a massive physician shortage on the way, it’s more important now than ever to keep a close eye on how the country’s cardiologists—and their colleagues—are being paid.